Redmile Group LLC Confirmation of post offer intention statements (2142X)
April 30 2021 - 4:00AM
UK Regulatory
TIDMREDX
RNS Number : 2142X
Redmile Group LLC
30 April 2021
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED
UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014
WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL)
ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A
REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO
BE IN THE PUBLIC DOMAIN.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN
PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION
WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR
REGULATIONS OF THAT JURISDICTION.
THE FOLLOWING ANNOUNCEMENT IS BEING MADE PURSUANT TO THE
REQUIREMENTS OF RULE 19.6(C) OF THE CITY CODE ON TAKEOVERS AND
MERGERS (THE "CODE"), WHICH, INTER ALIA, REQUIRES A PARTY TO AN
OFFER TO MAKE AN ANNOUNCEMENT AT THE END OF A PERIOD OF 12 MONTHS
FROM THE DATE ON WHICH THE OFFER PERIOD ENDED CONFIRMING WHETHER IT
HAS TAKEN, OR NOT TAKEN, THE COURSE OF ACTION SET OUT IN ITS STATED
INTENTIONS.
30 April 2021
RM Special Holdings 3, LLC,
a special purpose vehicle wholly-owned
by funds managed or advised by Redmile Group, LLC
Rule 19.6(c) confirmation of post-offer intention statements
with regard to Redx Pharma plc
RM Special Holdings 3 LLC ("Redmile" or the "Company") announces
that, further to the completion of its recommended mandatory cash
offer to acquire the entire issued and to be issued ordinary share
capital of Redx Pharma Plc ("Redx"), other than the shares already
held by Redmile, which was declared unconditional on 9 April 2020,
the Company has duly confirmed in writing to The Panel on Takeovers
and Mergers in accordance with the requirements of Rule 19.6(c) of
the Code that the Company has complied with its post-offer
statements of intent made pursuant to Rules 2.7(c)(iv) and 24.2 of
the Code, as originally detailed in its announcement of 13 March
2020 and the Offer Document published on 9 April 2020.
Enquiries:
SPARK Advisory Partners Limited
(Financial Adviser to Redmile) Telephone: 020 3368 3550
Matt Davis
Redmile : Telephone: +1 415 489 9980
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
OUPFIFEDSRIIVIL
(END) Dow Jones Newswires
April 30, 2021 04:00 ET (08:00 GMT)
Redx Pharma (LSE:REDX)
Historical Stock Chart
From Sep 2024 to Oct 2024
Redx Pharma (LSE:REDX)
Historical Stock Chart
From Oct 2023 to Oct 2024